Sagittarius Life Science Corp. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 153.726 million compared to TWD 135.270 million a year ago. Operating loss was TWD 19.098 million compared to TWD 22.457 million a year ago. Net loss was TWD 18.337 million compared to TWD 23.587 million a year ago. Basic loss per share was TWD 0.56 compared to TWD 0.72 a year ago. For the half year, sales was TWD 301.200 million compared to TWD 284.112 million a year ago. Operating loss was TWD 42.333 million compared to TWD 37.491 million a year ago. Net loss was TWD 40.473 million compared to TWD 33.892 million a year ago. Basic loss per share was TWD 1.24 compared to TWD 1.04 a year ago.